EMA renders negative trend vote on XBiotech's MAA for colorectal cancer candidate antibody April 21, 2017
EMA grants orphan drug designation to inebilizumab for neuromyelitis optica spectrum disorder March 30, 2017
EMA committee recommends approval of dinutuximab beta for the treatment of high-risk neuroblastoma March 29, 2017
RSS